Estrogen partial agonist that builds bone without uterine proliferation: Will accelerate its IND to file by the end of 1995; the previous target was 1996.

Ligand Pharmaceuticals Inc. (LGND), San Diego Product: Estrogen partial agonist that builds bone without uterine proliferation Indication: Osteoporosis Status: Will accelerate its IND to file by the e...